Literature DB >> 26580119

Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells.

Huijun Shi1,2,3, Qiang Fu1,2,3, Guozhong Li1,3, Yan Ren4, Shengwei Hu5, Wei Ni5, Fei Guo4, Mengting Shi5, Luping Meng1, Hui Zhang1, Jun Qiao1, Zhiru Guo1, Chuangfu Chen1.   

Abstract

Since the first report of induced pluripotent stem cells (iPSCs) by Takahashi and Yamanaka, numerous attempts have been made to derive iPSCs from other species via the ectopic expression of defined factors. Sheep iPSCs (siPSCs) have significant potential for biotechnology and agriculture. Although several groups have described siPSCs, the reprogramming efficiency was extremely low. The exogenous transgenes could be not silenced in the iPSCs, which hampered their development and application. Here, we report that p53 knockdown and antisilencing function 1A (ASF1A) overexpression promoted iPSC generation from sheep kidney cells (SKCs). Compared with transduction with eight human defined transcription factors (Oct4, Sox2, Klf4, c-Myc, Nanog, Lin28, hTERT, and SV40LT), the additional introduction of p53 RNA interference (RNAi) and/or ASF1A in the presence of small-molecule compounds [vitamin C (Vc) and valproic acid (VPA)] greatly improved the efficiency of sheep iPSC generation. The siPSCs exhibited morphological features similar to mouse embryonic stem cells (ESCs) and were positive for alkaline phosphatase and, pluripotent marker genes (Oct4, Nanog, Sox2, Rex1, TRA-1-60, TRA-1-81, and E-cadherin). Furthermore, these cells exhibited a normal karyotype of 54 chromosomes and were able to differentiate into all three germ layers both in vitro and in vivo. Moreover, the exogenous genes were silenced in siPSCs when p53 small hairpin RNA (shRNA) and ASF1A were added. Our results may help to reveal the role of p53 and ASF1A in sheep somatic cell reprogramming and provide an efficient approach to reprogramming sheep somatic cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26580119      PMCID: PMC4677545          DOI: 10.1089/cell.2015.0039

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  40 in total

Review 1.  p53: guardian of reprogramming.

Authors:  Sergio Menendez; Suzanne Camus; Juan Carlos Izpisua Belmonte
Journal:  Cell Cycle       Date:  2010-10-09       Impact factor: 4.534

Review 2.  p53 and stem cells: new developments and new concerns.

Authors:  Tongbiao Zhao; Yang Xu
Journal:  Trends Cell Biol       Date:  2010-01-12       Impact factor: 20.808

3.  Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors.

Authors:  Lei Bao; Lixiazi He; Jijun Chen; Zhao Wu; Jing Liao; Lingjun Rao; Jiangtao Ren; Hui Li; Hui Zhu; Lei Qian; Yijun Gu; Huimin Dai; Xun Xu; Jinqiu Zhou; Wen Wang; Chun Cui; Lei Xiao
Journal:  Cell Res       Date:  2011-01-11       Impact factor: 25.617

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

7.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells.

Authors:  Matthias Stadtfeld; Effie Apostolou; Francesco Ferrari; Jiho Choi; Ryan M Walsh; Taiping Chen; Steen S K Ooi; Sang Yong Kim; Timothy H Bestor; Toshi Shioda; Peter J Park; Konrad Hochedlinger
Journal:  Nat Genet       Date:  2012-03-04       Impact factor: 38.330

Review 9.  Large animal induced pluripotent stem cells as pre-clinical models for studying human disease.

Authors:  Jordan R Plews; Mingxia Gu; Michael T Longaker; Joseph C Wu
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  4 in total

Review 1.  Induced pluripotent stem cells from farm animals.

Authors:  Yue Su; Jiaqi Zhu; Saleh Salman; Young Tang
Journal:  J Anim Sci       Date:  2020-11-01       Impact factor: 3.159

2.  Reciprocity of Action of Increasing Oct4 and Repressing p53 in Transdifferentiation of Mouse Embryonic Fibroblasts into Cardiac Myocytes.

Authors:  Hongran Wang; Shuying Zhao; Michelle Barton; Todd Rosengart; Austin J Cooney
Journal:  Cell Reprogram       Date:  2018-02       Impact factor: 1.987

3.  miR-200c-141 Enhances Sheep Kidney Cell Reprogramming into Pluripotent Cells by Targeting ZEB1.

Authors:  Yunfeng Zhang; Yanhua He; Peng Wu; Shengwei Hu; Yanyan Zhang; Chuangfu Chen
Journal:  Int J Stem Cells       Date:  2021-11-30       Impact factor: 2.500

Review 4.  iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams.

Authors:  Daina Martínez-Falguera; Oriol Iborra-Egea; Carolina Gálvez-Montón
Journal:  Biomedicines       Date:  2021-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.